ImmunityBio (IBRX) Other Non-Current Assets (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Other Non-Current Assets of $378000.0 for Q1 2026, little changed year-over-year from $378000.0 in Q1 2025, and down 91.66% quarter-over-quarter from $4.5 million in Q4 2025.
ImmunityBio (IBRX) Other Non-Current Assets (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Other Non-Current Assets for 13 consecutive years, with $378000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $378000.0; the TTM figure through Mar 2026 stood at $378000.0 (changed 0.0% YoY), while the FY2025 annual figure was $4.5 million, up 1.82% from the prior year.
- Other Non-Current Assets declined to $378000.0 in Q1 2026 per IBRX's latest filing, from $4.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $6.5 million in Q1 2022 and bottomed at $378000.0 in Q1 2025.
- Historically, Other Non-Current Assets has averaged $3.6 million across 5 years, with a median of $3.8 million in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 3518.44% — and 2025, when it sank 86.15%.
- ImmunityBio's Other Non-Current Assets stood at $4.9 million in 2022, then plunged by 40.74% to $2.9 million in 2023, then soared by 54.48% to $4.4 million in 2024, then increased by 1.82% to $4.5 million in 2025, then sank by 91.66% to $378000.0 in 2026.
- Business Quant data shows IBRX's Other Non-Current Assets at $378000.0 in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn | 15.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.40 Mn |
| Mar 31, 2026 | 378,000.00 |
| Dec 31, 2025 | 4.53 Mn |
| Sep 30, 2025 | 4.47 Mn |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | 378,000.00 |
| Dec 31, 2024 | 4.45 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 2.88 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 3.77 Mn |
| Mar 31, 2023 | 4.55 Mn |
| Dec 31, 2022 | 4.86 Mn |
| Sep 30, 2022 | 5.13 Mn |
| Jun 30, 2022 | 6.02 Mn |
| Mar 31, 2022 | 6.48 Mn |
| Dec 31, 2021 | 6.78 Mn |
| Sep 30, 2021 | 7.44 Mn |